Shinpoong Pharmaceutical Co.,Ltd (KRX:019170)
South Korea flag South Korea · Delayed Price · Currency is KRW
8,440.00
-690.00 (-7.56%)
At close: Jun 8, 2026

KRX:019170 Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
52,14647,43341,98643,80041,69127,637
Short-Term Investments
24,46624,07314,47516,24514,22664,599
Trading Asset Securities
---535.69-465.97
Cash & Short-Term Investments
76,61271,50656,46160,58155,91792,702
Cash Growth
39.35%26.65%-6.80%8.34%-39.68%-51.37%
Accounts Receivable
67,50472,53870,16373,66182,28981,865
Other Receivables
726.72784.12,1558,0838,0817,860
Receivables
68,43673,52872,52381,94590,57689,925
Inventory
59,10158,47655,38253,92346,89547,707
Prepaid Expenses
1,2031,2252,757766.581,008900.48
Other Current Assets
3,7682,0012,1991,7192,1471,764
Total Current Assets
209,120206,736189,321198,935196,542232,997
Property, Plant & Equipment
106,976108,728115,398118,638113,760116,884
Long-Term Investments
43,09823,08224,89621,10729,33628,571
Other Intangible Assets
4,9285,0865,0065,7696,9318,971
Long-Term Deferred Tax Assets
1,0841,0872,826475.256,6289,086
Other Long-Term Assets
6,6647,7414,6335,1598,3391,841
Total Assets
371,878352,466342,093350,084361,536398,350
Accounts Payable
6,9317,0979,9988,94111,42812,060
Accrued Expenses
7,1426,4079,02113,8567,3007,057
Short-Term Debt
40,32641,19147,30545,000-248.11
Current Portion of Long-Term Debt
2,4002,4001,400---
Current Portion of Leases
559.57764.99951.49932.481,487719.94
Current Income Taxes Payable
226.32300112.5118.11-133.02
Other Current Liabilities
7,8138,7507,0567,5376,9528,332
Total Current Liabilities
65,39866,90975,84476,38527,16728,550
Long-Term Debt
11,08211,3744,600---
Long-Term Leases
141.72126.18340.84218.96441.51212.67
Pension & Post-Retirement Benefits
-----7,065
Other Long-Term Liabilities
2,9963,3293,2182,6983,1692,197
Total Liabilities
79,61881,73984,00379,30130,77838,025
Common Stock
27,59227,59227,59227,59227,59227,592
Additional Paid-In Capital
239,763215,780213,592213,592213,592213,592
Retained Earnings
49,60350,77138,94355,331115,830144,925
Treasury Stock
-1,626-8,734-8,734-8,734-8,734-8,734
Comprehensive Income & Other
-23,874-15,434-14,573-18,196-18,673-18,118
Total Common Equity
291,458269,975256,821269,586329,607359,257
Minority Interest
802.22752.641,2691,1961,1511,067
Shareholders' Equity
292,260270,728258,090270,782330,758360,324
Total Liabilities & Equity
371,878352,466342,093350,084361,536398,350
Total Debt
54,50955,85654,59746,1511,9281,181
Net Cash (Debt)
22,10215,6501,86414,43053,98891,521
Net Cash Growth
891.33%739.66%-87.08%-73.27%-41.01%-51.54%
Net Cash Per Share
426.20317.6436.46281.491053.181785.35
Filing Date Shares Outstanding
59.7549.2749.2749.2749.2749.27
Total Common Shares Outstanding
59.7549.2751.2651.2651.2651.26
Working Capital
143,722139,826113,477122,550169,375204,447
Book Value Per Share
4877.815479.395009.935258.956429.827008.22
Tangible Book Value
286,529264,889251,814263,817322,676350,286
Tangible Book Value Per Share
4795.335376.174912.275146.416294.626833.22
Land
15,97615,97615,97615,97615,97615,976
Buildings
123,459123,280121,660120,117121,946123,266
Machinery
114,832114,296112,867103,969104,000104,224
Construction In Progress
1,109762.971,1245,4264,231329.3